@article{7ad8bc561b854c118280120b9192287d,
title = "Long-term outcomes of frontline 90Y-ibritumomab tiuxetan in marginal zone lymphoma",
author = "Lossos, {Izidore S.} and Reis, {Isildinha M.} and Rosenblatt, {Joseph D.} and Alderuccio, {Juan Pablo}",
note = "Funding Information: ISL is supported by grant 1R01CA233945 from the National Cancer Institute, the Dwoskin, and Anthony Rizzo Families Foundations and Jaime Erin Follicular Lymphoma Research Consortium. JPA is a K12 Scholar supported by the National Cancer Institute of the National Institutes of Health under Award Number K12CA226330. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",
year = "2020",
doi = "10.1080/10428194.2020.1802449",
language = "English (US)",
volume = "61",
pages = "3234--3238",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "13",
}
